基本信息
views: 20
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr Mine Orlu is a pharmacist. She graduated from Istanbul University, Faculty of Pharmacy. She received her MSc on the subject of colon targeted microspheres in 2003, followed by a PhD about fluorescently-labeled nanoparticles and their interaction with lung cells in 2008 from Istanbul University, Faculty of Pharmacy. During her PhD studies, she held a 1-year visiting scientist post at King`s College London funded by Marie Curie Host Fellowship for Early Stage Training in the 6th Framework Programme of the European Commission. In respect to this, she was awarded an additional professional qualification, Euro-PhD in Advanced Drug Delivery, certified by Galenos Network & Saarland University, Saarbrucken, Germany. She started The School of Pharmacy, University of London in March 2008 as a post-doc for Prof Oya Alpar to perform studies on vaccine formulations. In her second post-doc position, she joined Prof Catherine Tuleu`s group as a Teaching and Research Fellow at UCL School of Pharmacy, Department of Pharmaceutics, Centre for Paediatric Pharmacy Research to work in the field of paediatric pharmaceutics and drug delivery. Her fellowship was funded by UK NIHR Medicines for Children Research Network (MCRN) from 2009 to 2012. As main part of her MCRN role as formulation research fellow, she worked closely with the MCRN Clinical Study Groups and provided pharmaceutical expertise in the development of patient-friendly formulations and appropriate trials supplies for the success of studies in children. Dr Orlu was appointed as Lecturer to develop a research agenda in `medicines for older people` in October 2012. She was promoted to Associate Professor in October 2018. She co-chairs `The Academy of Pharmaceutical Sciences - Age Related Medicines Focus Group`. Dr Orlu is member of the `European Forum for Good Clinical Practice` (EFGCP) `Geriatric Medicines Working Party` and associate member of the `European Paediatric Formulation Initiative` (EuPFI). She co-leads the `Understanding the Gastrointestinal Absorption-related Processes` (UNGAP) COST Action CA16205- Working Group 1: Special Populations. Dr Orlu is Programme Director for MSc Pharmaceutics at UCL.
Research Interests
Papers共 102 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Laura E McCoubrey, Fabiana Ferraro,Nidhi Seegobin, Jérémy Verin,Haya A Alfassam,Atheer Awad,Massimo Marzorati,Lynn Verstrepen,Jonas Ghyselinck, Julie De Munck,Jelle De Medts, Evi Steppe,
Journal of controlled release : official journal of the Controlled Release Society (2024): 163-178
Materials Today Advances (2024): 100509
Medical educationno. 5 (2024): 608-609
Alessia Favaron,Bart Hens, Maiara Camotti Montanha,Mark Mcallister,Irena Tomaszewska, Shaimaa Moustafa, Marilia Alvarenga de Oliveira,Abdul W. Basit,Mine Orlu
REPRODUCTIVE BIOMEDICINE ONLINEno. 4 (2024): 103734-103734
Xiaoai Shen, John Ian Wilzon T. Dizon, Yin Kei Doris Chong, Qing He, Gui Fonseca, Tai On Tyrone Kwok,Pauline Luk, Sarah S.C. Chan, Diana Lee, Lai Han Zoe Ng,Mine Orlu, Terry Tin Wai Ng,
Nurse Education Today (2024): 106325-106325
CoRR (2024)
Cited0Views0EIBibtex
0
0
Age and Ageingno. Supplement_2 (2023)
Load More
Author Statistics
#Papers: 102
#Citation: 2134
H-Index: 24
G-Index: 44
Sociability: 6
Diversity: 3
Activity: 110
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn